🇺🇸 FDA
Patent

US 12281073

Substituted piperidine compound and use thereof

granted A61PA61P25/00

Quick answer

US patent 12281073 (Substituted piperidine compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P25/00